Asarfi Hospital FY26: Growth powered by higher realizations, with capacity expansion setting up the next leg

Q4 FY26 consolidated revenue from operations was INR 45.24 crore and FY26 consolidated revenue from operations was INR 173.5 crore.

FY26 consolidated EBITDA was INR 35.28 crore at about 20 percent margin, and consolidated PAT was INR 16.66 crore at about 10 percent margin.

In FY26, the super-specialty unit had 285 beds with 56 percent occupancy and ARPOB of INR 23,020. The cancer unit had 65 beds with 42 percent occupancy and ARPOB of INR 37,428.

The presentation attributes it to lower patient volumes and a temporary pause in Ayushman Bharat cases due to delayed and reduced reimbursements.

It states plans to increase super-specialty beds from 285 to 350 (demand contingent) and to expand the cancer hospital from 65 to 150 beds by end of FY27.

It is a partnership with Gleneagles Hospital, Chennai. Consultation and diagnostic services are planned to begin by Q1 FY27, while transplant procedures will start after final State Government approval.

The presentation states targets of 500 plus beds, INR 400 crore revenue, ARPOB of INR 32K to 35K, and EBITDA margin of 23 to 25 percent.